We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Chemical Profiling and Biological Activity of Psydrax dicoccos Gaertn
Summary
This study profiled the chemical composition and biological activity of Psydrax dicoccos leaf and bark extracts, testing their potential against breast cancer cells as a safer natural alternative to synthetic chemotherapy drugs.
Breast cancer is one of the deadliest diseases in women with a mortality rate of 6.6%. Adverse effects of synthetic drugs have directed research toward safer alternatives such as natural compounds. This study focused on Psydrax dicoccos Gaertn, an evergreen tree abundantly distributed in Tamil Nadu (India) for its possible application against breast cancer cells. P. dicoccos leaf methanol extract, found within a wide range of phytochemicals, demonstrated cytotoxic effects against MCF7 breast cancer cells at IC50 of 34 μg/mL. The extract exhibited good antioxidant activities against DPPH• (62%) and ABTS•+ (80%), as well as concentration-dependent (100-800 μg/mL) anti-inflammatory potential of 18-60% compared to standards, ascorbic acid or aspirin, respectively. Moreover, even low extract concentrations (10 μg/mL) inhibited the growth of Escherichia coli (1.9 ± 0.6 mm) and Pseudomonas aeruginosa (2.3 ± 0.7 mm), thus showing high antimicrobial and anti-inflammatory potential. GC-MS and LC-MS analyses identified 31 and 16 components, respectively, of which selected compounds were used to evaluate the interaction between key receptors (AKT-1, COX-2, and HER-2) of breast cancer based on binding energy (ΔG) and inhibition constant (Ki). The results indicate that bioactive compounds from P. dicoccos have potential against breast cancer cells, but further evaluations are needed.
Sign in to start a discussion.
More Papers Like This
Nature's Chemical Treasure Trove
This introductory chapter explores the diversity and complexity of natural chemical compounds, reviewing examples from enzyme biochemistry, plant alkaloids, and secondary metabolites to illustrate the breadth of nature's chemical repertoire with implications for drug discovery and biotechnology.
Marine Natural Products: A Source of Novel Anticancer Drugs
This review explores marine natural products as potential sources for new anticancer drugs, highlighting compounds derived from marine plants, algae, bacteria, fungi, and invertebrates. Researchers found that marine organisms produce diverse bioactive metabolites with unique chemical structures that show promise against cancer cells. The study underscores the ocean as a largely untapped reservoir of compounds that could lead to novel therapeutic approaches.
Bioactive Compounds and Their Derivatives: An Insight into Prospective Phytotherapeutic Approach against Alzheimer’s Disease
Researchers reviewed natural bioactive compounds from plant sources for their potential neuroprotective effects related to Alzheimer's disease. The study highlights how these compounds may modulate molecular mechanisms involved in disease development, while noting challenges such as limited bioavailability and blood-brain barrier permeability.
Effects of grafting on chemical constituents, toxicological properties, antithrombotic activity, and myocardial infarction protection of styrax secreted from the trunk of Liquidambar orientalis Mill
Researchers grafted Liquidambar orientalis, the source of the medicinal balsam styrax, onto the widely distributed L. formosana rootstock to address resource shortages. Chemical analysis and biological testing compared the composition and therapeutic properties of styrax from grafted plants with that from the original endangered species.
Uncovering the Anticancer Potential of Polydatin: A Mechanistic Insight
This review examines the anticancer mechanisms of polydatin, a natural stilbenoid compound, detailing its ability to inhibit tumor growth through antioxidant, anti-inflammatory, and apoptotic pathways across multiple cancer types.